ETVAX: From Concepts to Demonstrated Clinical Efficacy

Ann-Mari Svennerholm1

  • 1Department of Microbiology and Immunology, Institute of Biomedicine, Gothenburg University, 45030 Gothenburg, Sweden.

Microorganisms
|July 28, 2026
PubMed
Summary

An oral inactivated vaccine against enterotoxigenic Escherichia coli (ETEC) showed promising safety and efficacy. ETVAX protects children and travelers from ETEC-associated diarrhea, offering hope for disease prevention.